Downgraded CBT appears weak and likely headed lower, so it's best to avoid.
Let's see how the charts and indicators have shaped up.
DBX could bounce in the short-run, but then it looks ready decline to around $12 after reaching our $18 target.
These bearish bets are showing both technical and quantitative deterioration.
Two reasons to buy a stock are better than one. Right?
Don't expect an oversold bounce here.
Both names receive quant upgrades and have strong charts.
CXW, which was downgraded to hold, is vulnerable to further declines.
Here's another reason to be a buyer.
SOHU has been making lower lows and lower highs the past twelve months.